0.7791

2.19% 0.0167

Nexalin Technology Inc (NXL)

Overview News Price History Financials Discussions Forecast

Nexalin Technology Inc stock is traded at $0.7791, with a volume of 20,781. It is up +2.19% in the last 24 hours and down -19.68% over the past month. Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Previous Close:

$0.7624

Open:

$0.7473

24h Volume:

20,781

Relative Volume:

0.01

Market Cap:

$14.33M

Revenue:

$174.80K

Net Income/Loss:

$-8.85M

P/E Ratio:

-1.1313

EPS:

-0.6887

Net Cash Flow:

$-4.37M

1W Performance:

+39.62%

1M Performance:

-19.68%

6M Performance:

-17.99%

1Y Performance:

-75.58%

1-Day Range:

$0.7473

$0.7899

1-Week Range:

$0.5601

$0.7899

52-Week Range:

$0.54

$3.87

Nexalin Technology Inc Stock (NXL) Company Profile

Name

Nexalin Technology Inc

Sector

Healthcare (1119)

Industry

Medical Devices (141)

Phone

(832) 260-0222

Address

1776 YORKTOWN, HOUSTON

Employee

Twitter

Next Earnings Date

2025-12-03

Latest SEC Filings

NXL's Discussions on Twitter

Compare NXL with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
NXL Nexalin Technology Inc	0.7684	14.22M	174.80K	-8.85M	-4.37M	-0.6887
ABT Abbott Laboratories	127.01	222.19B	43.84B	13.90B	6.92B	7.9725
BSX Boston Scientific Corp	98.50	144.97B	19.35B	2.78B	3.82B	1.8696
SYK Stryker Corp	365.06	140.12B	24.38B	2.94B	4.07B	7.6159
MDT Medtronic Plc	100.71	128.60B	34.76B	4.79B	5.21B	3.7017
EW Edwards Lifesciences Corp	84.68	49.82B	5.88B	1.34B	799.60M	2.3489

Nexalin Technology Inc Stock (NXL) Latest News

Jan 03, 2026

Is Nexalin Technology Inc a good long term investmentFibonacci Retracement Levels & Free Technical Analysis and Insights - earlytimes.in

Jan 03, 2026

Dec 29, 2025

Nexalin Technology announces effective registration statement - MSN

Dec 29, 2025

Dec 26, 2025

Returns Recap: Why Nexalin Technology Inc stock remains resilientDay Trade & Verified High Yield Trade Plans - moha.gov.vn

Dec 26, 2025

Dec 21, 2025

Can Nexalin Technology Inc. Equity Warrant stock deliver strong Q4 earnings2025 Trading Recap & Daily Oversold Stock Bounce Ideas - Улправда

Dec 21, 2025

Nexalin Technology and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Daily Commercial

Dec 21, 2025

Dec 20, 2025

Why retail investors favor Nexalin Technology Inc. Equity Warrant stock2025 Trading Recap & Free Community Supported Trade Ideas - Улправда

Dec 20, 2025

Will Nexalin Technology Inc. stock outperform value stocksEarnings Trend Report & Low Risk High Win Rate Picks - Улправда

Dec 20, 2025

How Nexalin Technology Inc. Equity Warrant stock performs after earnings2025 Price Momentum & Weekly High Momentum Picks - Улправда

Dec 20, 2025

Dec 19, 2025

Is Nexalin Technology Inc. Equity Warrant stock a safe haven assetQuarterly Market Summary & Risk Adjusted Buy/Sell Alerts - ulpravda.ru

Dec 19, 2025

Fed Watch: Is Nexalin Technology Inc. stock supported by innovation pipeline2025 Price Momentum & Technical Confirmation Trade Alerts - Улправда

Dec 19, 2025

Is Nexalin Technology Inc. Equity Warrant stock in correction or buying zoneProduct Launch & Verified Momentum Stock Watchlist - Улправда

Dec 19, 2025

Why Nexalin Technology Inc. stock attracts high net worth investorsMarket Sentiment Summary & Risk Controlled Stock Alerts - DonanımHaber

Dec 19, 2025

Why Nexalin Technology Inc. stock could be next big winner2025 Price Momentum & Free Real-Time Volume Trigger Notifications - DonanımHaber

Dec 19, 2025

Is Nexalin Technology Inc. stock a dividend growth opportunityWeekly Gains Summary & Verified Entry Point Detection - Улправда

Dec 19, 2025

Will Nexalin Technology Inc. Equity Warrant stock deliver consistent dividendsMarket Growth Review & Stock Timing and Entry Methods - DonanımHaber

Dec 19, 2025

Is Nexalin Technology Inc. stock supported by innovation pipelineJuly 2025 Big Picture & Daily Technical Stock Forecast Reports - Улправда

Dec 19, 2025

Can Nexalin Technology Inc. Equity Warrant stock beat market expectations this quarter2025 Key Highlights & Expert Approved Trade Ideas - DonanımHaber

Dec 19, 2025

Dec 18, 2025

Will Nexalin Technology Inc. stock maintain growth storyTrade Risk Assessment & Safe Entry Point Alerts - Улправда

Dec 18, 2025

VIX Spike: Is Nexalin Technology Inc. Equity Warrant stock a safe haven assetJuly 2025 Macro Moves & Free Community Consensus Stock Picks - Улправда

Dec 18, 2025

Why Nexalin Technology Inc. stock is favored by pension fundsJuly 2025 Drop Watch & Technical Entry and Exit Alerts - Улправда

Dec 18, 2025

RSI Check: Will Nexalin Technology Inc. stock maintain growth storyJuly 2025 Pullbacks & Smart Money Movement Alerts - Улправда

Dec 18, 2025

Dec 16, 2025

Nexalin Technology (NASDAQ:NXL) Shares Down 10.9% – Time to Sell? - Defense World

Dec 16, 2025

Dec 09, 2025

What analysts say about Nexalin Technology Inc Equity Warrant stockEarnings Miss Alerts & Superior Capital Trading Plans - earlytimes.in

Dec 09, 2025

Dec 07, 2025

Market Overview: Will Nexalin Technology Inc stock outperform value stocksTrade Entry Report & Low Risk Investment Opportunities - moha.gov.vn

Dec 07, 2025

Dec 06, 2025

Nexalin Technology, Inc. Unveils Advanced Neurostimulation Technology - TradingView — Track All Markets

Dec 05, 2025

Will Nexalin Technology Inc. Equity Warrant stock reach Wall Street targetsTreasury Yields & Real-Time Stock Entry Alerts - Newser

Dec 05, 2025

Dec 04, 2025

Nexalin advances Alzheimer’s device after FDA meeting By Investing.com - Investing.com South Africa

Dec 04, 2025

Dec 03, 2025

Nexalin Technology completes FDA Q-submission meeting for Gen-2 Sync - marketscreener.com

Dec 03, 2025

Nexalin advances Alzheimer’s device after FDA meeting - Investing.com

Dec 03, 2025

Nexalin Technology Completes FDA Q-Submission Meeting for - GlobeNewswire

Dec 03, 2025

Nexalin Technology Completes FDA Q-Submission Meeting for Gen-2 SYNC™ Neurostimulation Console in Alzheimer’s Disease Program - Sahm

Dec 03, 2025

Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on December 4 - markets.businessinsider.com

Dec 03, 2025

How Nexalin Technology Inc. stock trades before earnings2025 Trading Recap & Risk Controlled Stock Alerts - Newser

Dec 03, 2025

Dec 02, 2025

Nexalin Technology earnings missed by $0.01, revenue fell short of estimates - Investing.com Canada

Dec 02, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Dec 02, 2025

Nov 28, 2025

Volume Summary: Is Nexalin Technology Inc. Equity Warrant stock supported by strong cash flows2025 Technical Patterns & Smart Swing Trading Alerts - BỘ NỘI VỤ

Nov 28, 2025

Nov 27, 2025

Investors in cash trouble should check out Nexalin Technology Inc (NXL) - Setenews

Nov 27, 2025

Nov 24, 2025

Nexalin Technology (NASDAQ:NXL) Rating Lowered to Sell at Wall Street Zen - Defense World

Nov 24, 2025

Nov 22, 2025